Immunohistochemistry in the Diagnosis of Hepatocellular Carcinoma
- PMID: 28506367
- DOI: 10.1016/j.gtc.2017.01.006
Immunohistochemistry in the Diagnosis of Hepatocellular Carcinoma
Abstract
Hepatocellular carcinoma (HCC) can be difficult to distinguish from its mimics, including metastatic tumor, benign hepatocellular lesion, and high-grade dysplastic nodule, especially when limited biopsy material is available. Hence, the judicious use of immunohistochemical stains is necessary to establish a correct diagnosis. This article describes advantages and disadvantages of immunohistochemical markers that are most commonly used to distinguish between these lesions. Diagnostic workup of malignant liver mass (HCC and its histologic variants vs metastatic tumor) as well as well-differentiated hepatocellular lesion (well-differentiated HCC vs focal nodular hyperplasia vs hepatocellular adenoma) is also discussed.
Keywords: Focal nodular hyperplasia; Hepatocellular adenoma; Hepatocellular carcinoma; Immunohistochemistry; Well-differentiated hepatocellular lesion.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Application of Immunohistochemistry in the Pathological Diagnosis of Liver Tumors.Int J Mol Sci. 2021 May 28;22(11):5780. doi: 10.3390/ijms22115780. Int J Mol Sci. 2021. PMID: 34071338 Free PMC article. Review.
-
Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions.Arch Pathol Lab Med. 2008 Nov;132(11):1723-8. doi: 10.5858/132.11.1723. Arch Pathol Lab Med. 2008. PMID: 18976006
-
[Expression and clinicopathologic significance of GPC3 and other antibodies in well-differentiated hepatocellular carcinoma].Zhonghua Bing Li Xue Za Zhi. 2011 Jan;40(1):11-6. Zhonghua Bing Li Xue Za Zhi. 2011. PMID: 21429352 Chinese.
-
Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.Hum Pathol. 2014 May;45(5):976-83. doi: 10.1016/j.humpath.2013.12.011. Epub 2014 Jan 8. Hum Pathol. 2014. PMID: 24746201
-
Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens.Hum Pathol. 2017 May;63:1-13. doi: 10.1016/j.humpath.2016.12.025. Epub 2017 Jan 11. Hum Pathol. 2017. PMID: 28087475 Review.
Cited by
-
Biliary Atresia: A Complex Hepatobiliary Disease with Variable Gene Involvement, Diagnostic Procedures, and Prognosis.Diagnostics (Basel). 2022 Jan 27;12(2):330. doi: 10.3390/diagnostics12020330. Diagnostics (Basel). 2022. PMID: 35204421 Free PMC article. Review.
-
PTEN deficiency potentiates HBV-associated liver cancer development through augmented GP73/GOLM1.J Transl Med. 2024 Mar 8;22(1):254. doi: 10.1186/s12967-024-04976-4. J Transl Med. 2024. PMID: 38459588 Free PMC article.
-
Microarray-based Detection of Critical Overexpressed Genes in the Progression of Hepatic Fibrosis in Non-alcoholic Fatty Liver Disease: A Protein-protein Interaction Network Analysis.Curr Med Chem. 2024;31(23):3631-3652. doi: 10.2174/0929867330666230516123028. Curr Med Chem. 2024. PMID: 37194229
-
Application of Immunohistochemistry in the Pathological Diagnosis of Liver Tumors.Int J Mol Sci. 2021 May 28;22(11):5780. doi: 10.3390/ijms22115780. Int J Mol Sci. 2021. PMID: 34071338 Free PMC article. Review.
-
Serum exosomal long noncoding RNA CRNDE as a prognostic biomarker for hepatocellular carcinoma.J Clin Lab Anal. 2021 Nov;35(11):e23959. doi: 10.1002/jcla.23959. Epub 2021 Oct 6. J Clin Lab Anal. 2021. PMID: 34612554 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous